News - Page 105 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

Post published:June 17, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM

FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM

Post published:June 16, 2022
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date

Post published:June 14, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #106 – DMT Study Skips Set and Setting; Cybin Acquires Phase 1 Study; FDA Snubs Seamless Trial Design

Psychedelic Bulletin #106 – DMT Study Skips Set and Setting; Cybin Acquires Phase 1 Study; FDA Snubs Seamless Trial Design

Post published:June 13, 2022
Post category:Psychedelic Bulletin

Read more about the article Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Post published:June 9, 2022
Post category:Press Release

Read more about the article Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Post published:June 8, 2022
Post category:Press Release

Read more about the article Enveric Biosciences to Participate in Upcoming Conferences in June 2022

Enveric Biosciences to Participate in Upcoming Conferences in June 2022

Post published:June 8, 2022
Post category:Press Release

Read more about the article PharmaTher Announces Positive Results from Study of KETABET™ for Depression

PharmaTher Announces Positive Results from Study of KETABET™ for Depression

Post published:June 7, 2022
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:June 6, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #105 – UK Won’t Foot the Bill for Spravato; Another KAP Provider Launches; Canadian Province Decriminalises Possession of MDMA and Other Drugs

Psychedelic Bulletin #105 – UK Won’t Foot the Bill for Spravato; Another KAP Provider Launches; Canadian Province Decriminalises Possession of MDMA and Other Drugs

Post published:June 3, 2022
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.